Health Policy

Change and growth in our health care system are driven not only by federal and state regulations and legislation but also by private sector entrepreneurs who strive to expand choice, identify new treatments, and develop cures. 

Our Mission

The U.S. Chamber of Commerce's Health Policy Division identifies and advances legislative and regulatory policies to - 

  • Increase access to coverage and services

Scope of Issues

Through the Chamber's ability to convene dynamic groups of stakeholders and engage with our diverse member companies, we drive the dialogue and lead strategic partnerships to accomplish the following: 

 

Advocacy

The Chamber educates and advises member companies about key developments in Washington and collaborates with leaders in Congress and federal agencies to further our policy priorities. 

 

Policy Committees and Working Groups

The Health Policy Division represents our members' views by crafting policy positions through the Employee Benefits Committee (EBC), the Health Care Regulatory Task Force, the Supporting Opioid Solutions (SOS) Task Force, the Health Insurer Council, and the Health Policy Advisory Board. 

 

Recent Activity

Letters to CongressMay 04, 2021 - 1:45pm

U.S. Chamber Letter on H.R. 3, "Lower Drug Costs Now Act"

This Hill letter was sent to the Members of the U.S. House of Representatives, opposing H.R. 3, the "Lower Drug Costs Now Act." This bill is on the Legislative Leadership list for the “How They Voted” scorecard.

Above the FoldApr 29, 2021 - 12:30pm
U.S.-Israel

Expanding U.S.-Israel Partnerships in Health Innovation

Learn more about the U.S.-Israel Business Council's bilateral health innovation dialogue.

Press ReleaseApr 22, 2021 - 2:30pm

U.S. Chamber Opposes Government Price Controls That Will Destroy Jobs and Threaten Access

WASHINGTON, D.C. - The U.S. Chamber of Commerce strongly opposes H.R. 3, the “Lower Drug Costs Now Act of 2019,” which imposes government set price controls on prescription drugs. Members of Congress that refrain from cosponsoring this misguided legislation will receive credit for the Leadership component of the Chamber's “How They Voted” legislative scorecard.

Press ReleaseMar 17, 2021 - 12:00pm

U.S. Chamber: Medicare for All Would Decimate Employer-Sponsored Insurance Coverage for 180 Million Americans

WASHINGTON, D.C. – The U.S. Chamber of Commerce strongly opposes the introduction of a new House “Medicare for All” proposal because it would eliminate the private insurance coverage that more than 180 million Americans depend on for their healthcare needs.

Press ReleaseMar 12, 2021 - 1:00pm

U.S. Chamber of Commerce Statement on Vaccine Leadership following the Quad Summit

WASHINGTON, D.C. - Following the first meeting of heads of state from the United States, Australia, India and Japan under the Quadrilateral Security Dialogue (‘Quad’) framework, the U.S. Chamber of Commerce issued the following statement:

EventFeb 16, 2021 - 1:00pm to 2:00pm

Equality of Opportunity in Action: Bridging the Racial Gap for COVID-19 Treatments and Vaccines

The U.S. Chamber of Commerce’s Equality of Opportunity Initiative in partnership with the Chamber’s Discover & Deliver campaign, invites you to Equality of Opportunity in Action: Bridging the Racial Gap for COVID-19 Treatments and Vaccines on Tuesday, February 16 at 1:00 PM EST.

Letters to CongressFeb 02, 2021 - 11:00am

U.S. Chamber Letter on the American Rescue Plan

This Letter was sent to the President of the United States and to the Members of the United States Congress, on the Administration's "American Rescue Plan" and the Chamber's priorities for a bipartisan COVID-19 relief package.

Letters to CongressJan 15, 2021 - 9:15am

U.S. Chamber Letter on the Nomination of Alejandro Mayorkas to be Secretary of the Department of Homeland Security

This Hill Letter was sent to the Senate Committee on Homeland Security and Governmental Affairs, on the nomination of Alejandro Mayorkas to be Secretary of the Department of Homeland Security.

Above the FoldJan 08, 2021 - 10:00am
General Paul Ostrowski, director of supply, production and distribution for Operation Warp Speed.

The Path Forward: Operation Warp Speed Leader Sees Vaccine Distribution for Essential Workers, Elderly Starting Next Week

The latest on Operation Warp Speed from General Paul Ostrowski, director of supply, production and distribution for the program.

Press ReleaseDec 11, 2020 - 9:45pm

U.S. Chamber Applauds the Emergency Use Authorization of Pfizer’s Pandemic Vaccine

WASHINGTON, D.C. - U.S. Chamber of Commerce President Suzanne P. Clark today released the following statement regarding the Food and Drug Administration decision to grant an Emergency Use Authorization for Pfizer and BioNTech’s COVID-19 vaccine: